Answers are grounded in this paper and cite their sources.
Counterfeit drugs have long been a major concern. In search of a solution, this study conducted a systematic literature review. Using an automated content analysis of pharmaceutical blockchains, this study identifies the (1) unique characteristics of smart contracts on blockchain platforms in the pharmaceutical supply chain, (2) role of smart contracts to combat counterfeit drugs, and (3) avenues for future studies. Theoretical and managerial implications are discussed at the end of this paper.
No takes yet. Share an insight, caveat, or question.
Kordestani et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: